SPAG6-silencing enhances decitabine-induced apoptosis and demethylation of PTEN in SKM-1 cells and in a xenograft mouse model

References

• Sperling AS, Gibson CJ, Ebert BL. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat Rev Cancer. 2017;17(1):5–19.
   PubMed Web of Science ®Google Scholar
• Adès L, Itzykson R, Fenaux P. Myelodysplastic syndromes. Lancet. 2014; 383(9936):2239–2252.
   PubMed Web of Science ®Google Scholar
• Diamantopoulos PT, Kontandreopoulou CN, Symeonidis A, et al. Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome. Ann Hematol. 2019;98(6):1383–1392.
   PubMed Web of Science ®Google Scholar
• Ginder GD, Williams DC. Jr. Readers of DNA methylation, the MBD family as potential therapeutic targets. Pharmacol Ther. 2018;184:98–111.
   PubMed Web of Science ®Google Scholar
• Greenberg PL, Stone RM, Al-Kali A, et al. Myelodysplastic syndromes, Version 2.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15(1):60–87.
   PubMed Web of Science ®Google Scholar
• Voso MT, D'Alò F, Greco M, et al. Epigenetic changes in therapy-related MDS/AML. Chem Biol Interact. 2010;184(1–2):46–49.
   PubMed Web of Science ®Google Scholar
• Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet. 2000;9(16):2395–2402.
   PubMed Web of Science ®Google Scholar
• Hendrich B, Tweedie S. The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet. 2003;19(5):269–277.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Sapiro R, Kapfhamer D, et al. A sperm-associated WD repeat protein orthologous to Chlamydomonas PF20 associates with Spag6, the mammalian orthologue of Chlamydomonas PF16. Mol Cell Biol. 2002;22(22):7993–8004.
   PubMed Web of Science ®Google Scholar
• Neilson LI, Schneider PA, Van Deerlin PG, et al. cDNA cloning and characterization of a human sperm antigen (SPAG6) with homology to the product of the Chlamydomonas PF16 locus. Genomics. 1999;60(3):272–280.
   PubMed Web of Science ®Google Scholar
• Siliņa K, Zayakin P, Kalniņa Z, et al. Sperm-associated antigens as targets for cancer immunotherapy: expression pattern and humoral immune response in cancer patients. J Immunother. 2011;34(1):28–44.
   PubMed Web of Science ®Google Scholar
• Li W, Mukherjee A, Wu J, et al. Sperm Associated Antigen 6 (SPAG6) regulates fibroblast cell growth, morphology, migration and ciliogenesis. Sci Rep. 2015;5:16506.
   PubMed Web of Science ®Google Scholar
• Steinbach D, Schramm A, Eggert A, et al. Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia. Clin Cancer Res. 2006;12(8):2434–2441.
   PubMed Web of Science ®Google Scholar
• Steinbach D, Bader P, Willasch A, et al. Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia. Clin Cancer Res. 2015;21(6):1353–1359.
   PubMed Web of Science ®Google Scholar
• Yin J, Li X, Zhang Z, et al. SPAG6 silencing induces apoptosis in the myelodysplastic syndrome cell line SKM-1 via the PTEN/PI3K/AKT signaling pathway in vitro and in vivo. Int J Oncol. 2018;53(1):297–306.
   PubMed Web of Science ®Google Scholar
• Wu H, Goel V, Haluska FG. PTEN signaling pathways in melanoma. Oncogene. 2003;22(20):3113–3122.
   PubMed Web of Science ®Google Scholar
• de Unamuno Bustos B, Murria Estal R, Pérez Simó G, et al. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma. Br J Dermatol. 2018;179(2):394–404.
   PubMed Web of Science ®Google Scholar
• Chen J, Haanpää MK, Gruber JJ, et al. High-resolution bisulfite-sequencing of peripheral blood DNA methylation in early-onset and familial risk breast cancer patients. Clin Cancer Res. 2019;25(17):5301–5314.
   PubMed Web of Science ®Google Scholar
• Roh MR, Gupta S, Park KH, et al. Promoter methylation of PTEN is a significant prognostic factor in melanoma survival. J Investig Dermatol. 2016;136(5):1002–1011.
   PubMed Web of Science ®Google Scholar
• Soria JC, Lee HY, Lee JI, et al. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin Cancer Res. 2002;8(5):1178–1184.
   PubMed Web of Science ®Google Scholar
• Wei F, Wu Y, Wang Z, et al. Diagnostic significance of DNA methylation of PTEN and DAPK in thyroid tumors. Clin Endocrinol. 2020;93(2):187–195.
   PubMed Web of Science ®Google Scholar
• Phuong NT, Kim SK, Lim SC, et al. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells. Breast Cancer Res Treat. 2011;130(1):73–83.
   PubMed Web of Science ®Google Scholar
• Rajendran G, Shanmuganandam K, Bendre A, et al. Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas. J Neurooncol. 2011;104(2):483–494.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Matozaki S. The SKM-1 leukemic cell line established from a patient with progression to myelomonocytic leukemia in myelodysplastic syndrome (MDS)-contribution to better understanding of MDS. Leuk Lymphoma. 1995;17(3–4):335–339.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Matozaki S, Murayama T, et al. Establishment of a leukaemic cell line from a patient with acquisition of chromosomal abnormalities during disease progression in myelodysplastic syndrome. Br J Haematol. 1993;85(3):469–476.
   PubMed Web of Science ®Google Scholar
• Li X, Yang B, Wang L, et al. SPAG6 regulates cell apoptosis through the TRAIL signal pathway in myelodysplastic syndromes. Oncol Rep. 2017;37(5):2839–2846.
   PubMed Web of Science ®Google Scholar
• Jiang M, Chen Y, Deng L, et al. Upregulation of SPAG6 in myelodysplastic syndrome: knockdown inhibits cell proliferation via AKT/FOXO signaling pathway. DNA Cell Biol. 2019;38(5):476–484.
   PubMed Web of Science ®Google Scholar
• Zhang M, Luo J, Luo X, et al. SPAG6 silencing induces autophagic cell death in SKM-1 cells via the AMPK/mTOR/ULK1 signaling pathway. Oncol Lett. 2020;20(1):551–560.
   PubMed Web of Science ®Google Scholar
• Hasegawa N, Oshima M, Sashida G, et al. Impact of combinatorial dysfunctions of Tet2 and Ezh2 on the epigenome in the pathogenesis of myelodysplastic syndrome. Leukemia. 2017;31(4):861–871.
   PubMed Web of Science ®Google Scholar
• Morgan AE, Davies TJ, Mc Auley MT. The role of DNA methylation in ageing and cancer. Proc Nutr Soc. 2018;77(4):412–422.
   PubMed Web of Science ®Google Scholar
• Cimmino L, Dolgalev I, Wang Y, et al. Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell. 2017;170(6):1079–1095.e1020.
   PubMed Web of Science ®Google Scholar
• Hirsch CM, Nazha A, Kneen K, et al. Consequences of mutant TET2 on clonality and subclonal hierarchy. Leukemia. 2018;32(8):1751–1761.
   PubMed Web of Science ®Google Scholar
• Niu C, Li M, Zhu S, et al. Decitabine inhibits gamma delta T cell cytotoxicity by promoting KIR2DL2/3 expression. Front Immunol. 2018;9(9):617.
   PubMedGoogle Scholar
• Fu S, Hu W, Iyer R, et al. Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer. Cancer. 2011;117(8):1661–1669.
   PubMed Web of Science ®Google Scholar
• Lee V, Wang J, Zahurak M, et al. A phase I trial of a guadecitabine (SGI-110) and irinotecan in metastatic colorectal cancer patients previously exposed to irinotecan. Clin Cancer Res. 2018;24(24):6160–6167.
   PubMed Web of Science ®Google Scholar
• Singal R, Ramachandran K, Gordian E, et al. Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy. Clin Genitourin Cancer. 2015;13(1):22–31.
   PubMed Web of Science ®Google Scholar
• Wu P, Liu L, Weng J, et al. The synergistic effects of decitabine combined with Arsenic Trioxide (ATO) in the human myelodysplastic syndrome cell line SKM-1. Indian J Hematol Blood Transfus. 2016;32(4):412–417.
   PubMed Web of Science ®Google Scholar
• Zeng W, Dai H, Yan M, et al. Decitabine-induced changes in human myelodysplastic syndrome cell line SKM-1 are mediated by FOXO3A activation. J Immunol Res. 2017;2017:4302320.
   PubMed Web of Science ®Google Scholar